Hederasal (Dry Extract Of Hederae Folium (Der 4-8:1), Extracting Agent: Ethanol 30 % (M/M))

The extract is rich in saponins, especially hederacoside C, which stimulate bronchial secretions and enhance ciliary activity. This promotes mucociliary clearance, while mild anti‑inflammatory effects and irritation of airway sensory receptors help trigger a productive cough, aiding expectoration.

The appropriate dose of Hederasal is determined by the prescribing healthcare professional based on the specific product formulation, patient age, weight, and clinical condition. Patients should follow the prescriber’s instructions and the label directions provided with the medication.

Safety data for Hederasal in pregnancy and lactation are limited. It is generally advised to avoid use unless the potential benefit outweighs any possible risk and the decision is made by a qualified physician. Breastfeeding mothers should consult their doctor before taking the product.

To place an order, submit an enquiry on the Hederasal product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Hederasal provides a plant‑derived alternative to synthetic expectorants such as guaifenesin. Its saponin content offers both secretolytic and mild anti‑inflammatory actions, whereas many conventional agents primarily increase fluid secretion. Clinical choice depends on patient preference, tolerability, and physician assessment of efficacy.

Store Hederasal at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, direct sunlight and extreme heat. Ensure the container is tightly closed to maintain product stability throughout its shelf life.

Hederasal is taken orally, usually in the form of tablets, capsules or a liquid preparation, as directed by the prescribing clinician. It should be swallowed with water, and the dosing schedule (e.g., before meals or at bedtime) is defined by the healthcare provider.

Serious adverse reactions, although rare, include allergic responses such as hives, swelling, or anaphylaxis, and paradoxical bronchospasm that can worsen breathing difficulty. Any signs of severe skin rash, difficulty breathing, or sudden liver function changes should prompt immediate medical evaluation.

Individuals with known hypersensitivity to ivy leaf or any component of the formulation should avoid Hederasal. Patients taking anticoagulant therapy, those with uncontrolled liver disease, or anyone for whom a prescriber determines the risk outweighs the benefit should not use the product.